In a new twist in the ongoing PCSK9 patent saga, Amgen Inc. has asked the US Supreme Court to step in and answer a question that could determine the outcome of its litigation with Sanofi/Regeneron Pharmaceuticals Inc.
The companies are set to square off in a second jury trial over the validity of two Amgen patents, scheduled...





